Specific behaviour ‐ threat or injury to self or others ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global outcome Need for rescue drug · patients with psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in global outcome Need for rescue drug compared with BENZODIAZEPINE: c. MIDAZOLAM (low certainty).
1 finding from 1 review
Adverse drug effects · patients with psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in adverse effects ‐ general ‐ one or more drug‐related adverse effect compared with BENZODIAZEPINE: c. MIDAZOLAM (low certainty).
1 finding from 1 review
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Repeated need for tranquillisation ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality (N) Mean hospital stay: 2‐7 days
1 finding from 1 review
Morbidity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events other than hypoglycaemic episodes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to resolution of diabetic ketoacidosis (h) Mean hospital stay: 3‐5 days
1 finding from 1 review
Patient satisfaction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay
1 finding from 1 review
Hypoglycaemic episodes
Subcutaneous insulin lispro showed no clear difference in hypoglycaemic episodes (N) Mean hospital stay: 2‐7 days compared with intravenous regular insulin (low certainty).
1 finding from 1 review
Length of hospital stay
2 findings from 1 review
Adverse events other than hypoglycaemic episodes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to resolution of diabetic ketoacidosis (h) Mean hospital stay: 2‐4 days
1 finding from 1 review
Patient satisfaction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality (N) Mean hospital stay: 2‐7 days
1 finding from 1 review
Hypoglycaemic episodes
Subcutaneous insulin aspart showed no clear difference in hypoglycaemic episodes (N) Mean hospital stay: 3‐5 days compared with intravenous regular insulin (low certainty).
1 finding from 1 review
Intervention not reported
Patients still unwell at day 4 to 7 · People with fever
The intervention showed no clear difference in patients still unwell at day 4 to 7 (low certainty).
1 finding from 1 review